MAPK3 and prostate cancer: We also show that depletion of ARF1 by siRNA and CRISPR–Cas9 and inhibition of GA-localized ARF1 activation abolish ERK1/2 activation by CXCR4 and Gβγ translocation to the GA and suppress prostate cancer PC3 cell migration and invasion.